Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.9900
+0.0500 (2.58%)
NASDAQ· Last Trade: Jul 4th, 7:30 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors